Zobrazeno 1 - 10
of 509
pro vyhledávání: '"Burke GA"'
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib
Autor:
Prokoph, Nina, Matthews, Jamie D, Trigg, Ricky M, Montes-Mojarro, Ivonne A, Burke, GA Amos, Fend, Falko, Merkel, Olaf, Kenner, Lukas, Geoerger, Birgit, Johnston, Robert, Murray, Matthew J, Riguad, Charlotte, Brugières, Laurence, Turner, Suzanne D
Anaplastic large-cell lymphoma (ALCL) is a T-cell malignancy predominantly driven by the oncogenic anaplastic lymphoma kinase (ALK), accounting for approximately 15% of all paediatric non-Hodgkin lymphoma. Patients with central nervous system (CNS) r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::724728795b59d8a3e2afc791fc320b65
Autor:
Macartney RA; Nanotechnology & Integrated Bioengineering Centre (NIBEC), School of Engineering, Ulster University, York Street, Belfast BT15 1ED, UK; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. Electronic address: Macartney-R4@ulster.ac.uk., Weaver E; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Irwin R; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Wylie MP; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Burke GA; Nanotechnology & Integrated Bioengineering Centre (NIBEC), School of Engineering, Ulster University, York Street, Belfast BT15 1ED, UK., Lamprou DA; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. Electronic address: D.Lamprou@qub.ac.uk.
Publikováno v:
Biomaterials advances [Biomater Adv] 2024 Apr; Vol. 158, pp. 213765. Date of Electronic Publication: 2024 Jan 14.
Autor:
Lueza B; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France., Aupérin A; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France., Rigaud C; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France., Gross TG; Department of Pediatrics, Center for Cancer and Blood Diseases, Children's Hospital Colorado, Aurora, CO, USA., Pillon M; Pediatric Hematology and Oncology, University of Padova, Padua, Italy., Delgado RF; Pediatric Hematology and Oncology, University of Valencia, Valencia, Spain., Uyttebroeck A; Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Louvain, Belgium., Amos Burke GA; Department of Paediatric Haematology, Oncology and Palliative Care, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK., Zsíros J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Csóka M; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary., Simonin M; Department of Pediatric Oncology and Hematology, Armand Trousseau Hospital-APHP, Sorbonne University, Paris, France., Patte C; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France., Minard-Colin V; Département de Cancérologie de l'Enfant et l'adolescent, Gustave Roussy, Université Paris-Saclay, 94805, Villejuif, France.; INSERM 1015, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Bonastre J; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Université Paris-Saclay, 114 Rue Edouard Vaillant, 94805, Villejuif Cedex, France. julia.bonastre@gustaveroussy.fr.; Oncostat CESP - Labeled Ligue Contre le Cancer, INSERM 1018, Université Paris-Saclay, UVSQ, Villejuif, France. julia.bonastre@gustaveroussy.fr.
Publikováno v:
The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2024 Mar; Vol. 25 (2), pp. 307-317. Date of Electronic Publication: 2023 Apr 14.
Autor:
Beishuizen, Auke, Mellgren, Karin, Andrés, Mara, Auperin, Anne, Bacon, Chris M, Bomken, Simon, Burke, GA Amos, Burkhardt, Birgit, Brugieres, Laurence, Chiang, Alan KS, Damm-Welk, Christine, d'Amore, Emanuele, Horibe, Keizo, Kabickova, Edita, Khanam, Tasneem, Kontny, Udo, Klapper, Wolfram, Lamant, Laurence, Le Deley, Marie-Cecile, Loeffen, Jan, Macintyre, Elizabeth, Mann, Georg, Meyer-Wentrup, Friederike, Michgehl, Ulf, Minard-Colin, Veronique, Mussolin, Lara, Oschlies, Ilske, Patte, Catherine, Pillon, Marta, Reiter, Alfred, Rigaud, Charlotte, Roncery, Leila, Salaverria, Itziar, Simonitsch-Klupp, Ingrid, Uyttebroeck, Anne, Verdu-Amoros, Jaime, Williams, Denise, Woessmann, Wilhelm, Wotherspoon, Andrew, Wrobel, Grazyna, Zimmermann, Martin, Attarbaschi, Andishe, Turner, Suzanne D, European Intergroup for Childhood Non-Hodgkin Lymphoma
The European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) was established 25 years ago with the goal to facilitate clinical trials and research collaborations in the field both within Europe and worldwide. Since its inception, much progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08974a82feb6763d53f7325a3789ed71
Autor:
Trotman, Jamie, Armstrong, Ruth, Firth, Helen, Trayers, Claire, Watkins, James, Allinson, Kieren, Jacques, Thomas S, Nicholson, James C, Burke, GA Amos, Genomics England Research Consortium, Behjati, Sam, Murray, Matthew, Hook, Catherine E, Tarpey, Patrick
BACKGROUND: Whole-genome sequencing (WGS) of cancers is becoming an accepted component of oncological care, and NHS England is currently rolling out WGS for all children with cancer. This approach was piloted during the 100,000 genomes (100 K) projec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::277e69cbceb69b8eac8dd43cdd26951e
https://www.repository.cam.ac.uk/handle/1810/332877
https://www.repository.cam.ac.uk/handle/1810/332877
Autor:
Weaver E; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Macartney RA; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK; Nanotechnology & Integrated Bioengineering Centre (NIBEC), School of Engineering, Ulster University, York Street, Belfast BT15 1ED, UK., Irwin R; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Uddin S; Immunocore Ltd, 92 Park Dr, Milton, Abingdon OX14 4RY, UK., Hooker A; Immunocore Ltd, 92 Park Dr, Milton, Abingdon OX14 4RY, UK., Burke GA; Nanotechnology & Integrated Bioengineering Centre (NIBEC), School of Engineering, Ulster University, York Street, Belfast BT15 1ED, UK., Wylie MP; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK., Lamprou DA; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK. Electronic address: D.Lamprou@qub.ac.uk.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Jan 25; Vol. 650, pp. 123710. Date of Electronic Publication: 2023 Dec 13.
Autor:
Coorens, Tim HH, Collord, Grace, Lu, Wanhua, Mitchell, Emily, Ijaz, Jannat, Roberts, Thomas, Oliver, Thomas RW, Burke, GA Amos, Gattens, Michael, Dickens, Emmy, Nangalia, Jyoti, Tischkowitz, Marc, Anderson, John, Shlien, Adam, Godfrey, Anna L, Murray, Matthew J, Behjati, Sam
Therapy-related myeloid neoplasms (TMN) constitute one of the most challengingcomplications of cancer treatment.1 Whilst understanding of TMN pathogenesis remains fragmentary, genomic studies in adults have thus far refuted the notion that TMN simply
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bfb0d23268e999e6e4f8b88a4bb5ad
https://www.repository.cam.ac.uk/handle/1810/317248
https://www.repository.cam.ac.uk/handle/1810/317248
Autor:
Attarbaschi, Andishe, Abla, Oussama, Arias Padilla, Laura, Beishuizen, Auke, Burke, GA Amos, Brugières, Laurence, Bruneau, Julie, Burkhardt, Birgit, D'Amore, Emanuele SG, Klapper, Wolfram, Kontny, Udo, Pillon, Marta, Taj, Mary, Turner, Suzanne D, Uyttebroeck, Anne, Woessmann, Wilhelm, Mellgren, Karin
Pediatric-type follicular (PTFL), marginal zone (MZL), and peripheral T-cell lymphoma (PTCL) account each for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c62cfe58e9fa5bebf5d16aa0b97af6
https://www.repository.cam.ac.uk/handle/1810/304974
https://www.repository.cam.ac.uk/handle/1810/304974
Anaplastic large cell lymphoma (ALCL) is a T cell Non-Hodgkin Lymphoma that mainly presents in paediatric and young adult patients. The majority of cases express a chimeric fusion protein resulting in hyperactivation of anaplastic lymphoma kinase (AL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b9d13f0f7319d67fb03bbcb59c32e3
https://www.repository.cam.ac.uk/handle/1810/288850
https://www.repository.cam.ac.uk/handle/1810/288850
Autor:
Garland GD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK., Ducray SP; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK., Jahangiri L; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK.; Department of Life Sciences, Birmingham City University, Birmingham B15 3TN, UK., Pucci P; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK., Amos Burke GA; Department of Paediatric Oncology, Cambridge University Hospital NHS Trust, Cambridge CB5 8PD, UK., Monahan J; The European Bioinformatics Institute (EMBL EBI), Wellcome Genome Campus, Cambridge CB10 1SA, UK., Lai R; Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB T6G 2R3, Canada., Merkel O; Department of Pathology, Medical University Vienna, 1090 Vienna, Austria., Schiefer AI; Department of Pathology, Medical University Vienna, 1090 Vienna, Austria., Kenner L; Department of Pathology, Medical University Vienna, 1090 Vienna, Austria.; Unit of Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.; CBMed, 8010 Graz, Austria.; Christian Doppler Laboratory of Applied Metabolomics (CDL-AM), Medical University Vienna, 1090 Vienna, Austria., Bannister AJ; The Gurdon Institute, Cambridge CB2 1QN, UK., Turner SD; Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Cambridge CB2 0QQ, UK.; Central European Institute of Technology (CEITEC), Masaryk University, 601 77 Brno, Czech Republic.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Dec 29; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 29.